Emilia Arturo: Consider Submitting the Paper and Its Reviews for a Second Look Rapid Response From One of These Blood Journals
Emilia Arturo, Senior Managing Editor of Blood and Blood Global Hematology, reposted from Blood Journals Portfolio on LinkedIn:
”Have a paper already reviewed and rejected at another reputable hematology, immunology, or oncology journal?
Consider submitting the paper and its reviews for a Second Look Rapid Response from one of these Blood Journals!”
Quoting Blood Journals Portfolio‘s post:
”Submitting to a top medical journal can be a long process and not getting published can feel like a setback.
However, it doesn’t have to be the end of your manuscript’s journey.
The five specialized journals in the Blood Journals portfolio, Blood ICT, Blood RCI, Blood VTH, Blood Neoplasia, and Blood Global Hematology are offering authors a rapid second look.
If you have research within the scope of one of these journals, you could get published soon with the backing of the renowned Blood brand.
It’s simple:
- Update and submit a manuscript previously submitted to another reputable journal (with reviewer feedback)
- Receive an initial editorial assessment within just 3 business days
- Just 8 weeks from submission to publishing of first edition
Your work deserves to be seen. Learn more.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis